Package 0517-1820-01

Brand: chlorothiazide sodium

Generic: chlorothiazide sodium
NDC Package

Package Facts

Identity

Package NDC 0517-1820-01
Digits Only 0517182001
Product NDC 0517-1820
Product ID 0517-1820_2c97dd4f-150c-4fc0-9400-2d8305bb21b0
Description

1 VIAL in 1 CARTON (0517-1820-01) / 18 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2015-04-01
Brand chlorothiazide sodium
Generic chlorothiazide sodium
Sample Package No

Linked Drug Pages (1)

Chlorothiazide Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2c97dd4f-150c-4fc0-9400-2d8305bb21b0", "openfda": {"unii": ["SN86FG7N2K"], "rxcui": ["484152"], "spl_set_id": ["850960a3-9fe2-4999-81eb-b0ae9ba011bc"], "manufacturer_name": ["American Regent, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0517-1820-01)  / 18 mL in 1 VIAL", "package_ndc": "0517-1820-01", "marketing_start_date": "20150401"}], "brand_name": "Chlorothiazide Sodium", "product_id": "0517-1820_2c97dd4f-150c-4fc0-9400-2d8305bb21b0", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0517-1820", "generic_name": "Chlorothiazide Sodium", "labeler_name": "American Regent, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlorothiazide Sodium", "active_ingredients": [{"name": "CHLOROTHIAZIDE SODIUM", "strength": "500 mg/18mL"}], "application_number": "ANDA202561", "marketing_category": "ANDA", "marketing_start_date": "20150401", "listing_expiration_date": "20261231"}